SLGL
Sol-Gel Technologies Ltd.
$80.00
+2.59%
$224.8M
No data for this timeframe.
Vol
Market Cap$224.8M
Cap SizeMicro Cap
Insider Activity5B / 0S
Insider Net $$2.8M
SEC Reports3
Press Releases1
Recent Activity
May 28, 2026
SEC
Sol-Gel reported Q1 2026 revenue of $0.1M (down 89.5% YoY from $1.0M) and a net loss of $3.7M ($1.31/share), improved fr
6-K — Impact 6/10
May 28, 2026
SEC
Sol-Gel reported Q1 2026 EPS of -$1.31, a 62.6% beat vs consensus of -$2.86, but revenue fell 90% YoY to $0.1M due to a
PRESS-RELEASE — Impact 6/10
May 28, 2026
earnings
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
<p>NESS ZIONA, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Sol-Gel Technologies, Ltd.</strong
May 20, 2026
Insider
Opaleye Management Inc. bought 1,563 shares
10%+ Owner @ $64.43 ($100.7K)
May 13, 2026
Insider
Opaleye Management Inc. bought 1,937 shares
10%+ Owner @ $66.87 ($129.5K)
May 12, 2026
Insider
Opaleye Management Inc. bought 1,500 shares
10%+ Owner @ $67.98 ($102.0K)
Mar 24, 2026
SEC
Sol-Gel Technologies Ltd. (SLGL) has received SEC effectiveness for its registration statement, allowing it to proceed w
EFFECT — Impact 4/10
Mar 19, 2026
Press
Sol-Gel Technologies filed its 20-F for 2025, disclosing audited financial results and providing corporate updates. The
Impact 4/10
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$147.00 (Jan 2026)
Current $76.22
Low $110.00
Median $147.00
High $184.00
2 analysts
$110.00
$184.00
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 20, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Dec 22, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-3.33 ▼ -84.0% | $-3.33 — $-3.33 | 1 | |
| Next Q | $-3.45 ▼ -93.8% | $-3.45 — $-3.45 | -62% YoY | 1 |
| Current FY | $-8.26 ▼ -21.3% | $-13.03 — $-4.95 | -277% YoY | 3 |
| Next FY | $-10.88 | $-16.81 — $-4.95 | -32% YoY | 2 |
Latest Reports
MIXED
6-K
6/10
Sol-Gel reported Q1 2026 revenue of $0.1M (down 89.5% YoY from $1.0M) and a net loss of $3.7M ($1.31/share), improved fr
May 28, 2026
MIXED
PRESS-RELEASE
6/10
Sol-Gel reported Q1 2026 EPS of -$1.31, a 62.6% beat vs consensus of -$2.86, but revenue fell 90% YoY to $0.1M due to a
May 28, 2026
NEUTRAL
Press
4/10
Sol-Gel Technologies filed its 20-F for 2025, disclosing audited financial results and providing corporate updates. The
Mar 19, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Opaleye Management | BUY | $100.7K |
| May 13, 2026 | Opaleye Management | BUY | $129.5K |
| May 12, 2026 | Opaleye Management | BUY | $102.0K |
| Mar 24, 2026 | Opaleye Management | BUY | $2.5M |
| Feb 2, 2026 | Opaleye Management | BUY | $5.8K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 5 transactions. Net insider value: $2.8M ($2.8M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Opaleye Management Inc. | 10%+ Owner | BUY | 1,563 | $64.43 | $100.7K |
| May 13, 2026 | Opaleye Management Inc. | 10%+ Owner | BUY | 1,937 | $66.87 | $129.5K |
| May 12, 2026 | Opaleye Management Inc. | 10%+ Owner | BUY | 1,500 | $67.98 | $102.0K |
| Mar 24, 2026 | Opaleye Management Inc. | 10%+ Owner | BUY | 34,665 | $72.00 | $2.5M |
| Feb 2, 2026 | Opaleye Management Inc. | 10%+ Owner | BUY | 100 | $58.00 | $5.8K |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 1 neutral. Avg impact: 5.3/10.
MIXED
6-K
6/10
Sol-Gel reported Q1 2026 revenue of $0.1M (down 89.5% YoY from $1.0M) and a net loss of $3.7M ($1.31
May 28, 2026
MIXED
PRESS-RELEASE
6/10
Sol-Gel reported Q1 2026 EPS of -$1.31, a 62.6% beat vs consensus of -$2.86, but revenue fell 90% Yo
May 28, 2026
NEUTRAL
EFFECT
4/10
Sol-Gel Technologies Ltd. (SLGL) has received SEC effectiveness for its registration statement, allo
Mar 24, 2026
Historical analyst distribution (last covering-analyst action Jan 2026): 88% buy across 8 analysts — 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$147.00 mean target (Jan 2026)
$110.00 Low
$184.00 High
| Metric | Value |
|---|---|
| Current Price | $76.22 |
| Target Low | $110.00 |
| Target Mean | $147.00 |
| Target Median | $147.00 |
| Target High | $184.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-3.33 | $-3.33 | $-3.33 | — | -84.0% | — | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$-3.45 | $-3.45 | $-3.45 | -62.0% | -93.8% | — | $0.0B | 275.0% | 1 |
| Current FY 2026-12-31 |
$-8.26 | $-13.03 | $-4.95 | -277.3% | -21.3% | — | $0.0B | -100.0% | 3 |
| Next FY 2027-12-31 |
$-10.88 | $-16.81 | $-4.95 | -31.7% | — | 0↑ 1↓ | $0.0B | 0.0% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-3.330 | |
| 7d ago | $-2.900 | -0.430 |
| 30d ago | $-1.810 | -1.520 |
| 60d ago | $-1.810 | -1.520 |
| 90d ago | $-1.810 | -1.520 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 20, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Dec 22, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 28, 2026
earnings
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
<p>NESS ZIONA, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Sol-Gel Technologies, Ltd.</strong> (NASDAQ: SLGL), a dermatology company, pioneerin
May 21, 2026
earnings_calendar
SLGL Q1 2026 Earnings Scheduled — 2026-05-21
May 11, 2026
Clinical Trial
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Phase Phase 3 — ACTIVE_NOT_RECRUITING
May 11, 2026
clinical_trial_readout
T-90d Trial Readout: Patidegib Topical Gel (Phase 3)
Trial: Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Sponsor: Sol-Gel Techno
May 4, 2026
clinical_trial_readout
T-90d Trial Readout: Patidegib Topical Gel (Phase 3)
Trial: Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Sponsor: Sol-Gel Techno
May 3, 2026
clinical_trial_readout
T-90d Trial Readout: Patidegib Topical Gel (Phase 3)
Trial: Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Sponsor: Sol-Gel Techno
Mar 24, 2026
other
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Mar 23, 2026
earnings_calendar
SLGL Q4 2025 Earnings After Market Close — 2026-03-23
Mar 19, 2026
earnings
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025